Similar to ovarian and gastric cancers as mentioned above in invasion section, blockade of the HGF receptor pathway by administration of recombinant NK4, a four-kringle fragment of HGF which functions as its antagonist, inhibits growth, invasion, and distant metastasis of orthotopically implanted PDA cells. The gene discussed is HGF; the disease is gastric cancer.